A detailed history of Optas, LLC transactions in Haleon PLC stock. As of the latest transaction made, Optas, LLC holds 21,337 shares of HLN stock, worth $219,344. This represents 0.04% of its overall portfolio holdings.

Number of Shares
21,337
Previous 18,097 17.9%
Holding current value
$219,344
Previous $173,000 26.59%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 17, 2025

BUY
$9.02 - $10.67 $29,224 - $34,570
3,240 Added 17.9%
21,337 $219,000
Q4 2024

Jan 24, 2025

BUY
$9.23 - $10.71 $167,035 - $193,818
18,097 New
18,097 $173,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $47.5B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Optas, LLC Portfolio

Follow Optas, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.